ADVERTISEMENT
AstraZeneca, University of Oxford, vaccine, COVID-19, SARS-CoV-2, pandemic, coronavirus, vaccination, safety, Europe
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries

Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.

Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.

disease & medicine, microbiology

COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
Interim Report on Origin of SARS-CoV-2 Scrapped by WHO
Lisa Winter | Mar 5, 2021 | 2 min read
Instead, the full report will be available in mid-March.
COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
Variant Found in Brazil Could Evade Immunity from Past Infection
Lisa Winter | Mar 2, 2021 | 2 min read
The P.1 variant, which has also been detected in five US states, could be responsible for cases of reinfection, according to a preprint.
regeneron monoclonal antibody sars-cov-2 covid-19 pandemic coronavirus neutralization b.1.351 variant south africa REGN10987 casirivimab and REGN10933 imdevimab
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021 | 3 min read
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
COVID-19, SARS-CoV-2, Johnson & Johnson, Pfizer, Moderna, vaccine, vaccination, variant, FDA
US Authorizes a Third COVID-19 Vaccine
Asher Jones | Mar 1, 2021 | 2 min read
Johnson & Johnson’s one-shot immunization could reach people’s arms as early as March 2.
COVID-19, SARS-CoV-2, coronavirus, pandemic, virus, B.1.1.7, B.1.525, variant, UK
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Asher Jones | Feb 16, 2021 | 2 min read
B.1.525 shares a mutation with the B.1.351 variant first detected in South Africa that seems to allow the virus to dodge the immune system.
New Bacterium Linked to Chimp Deaths
Asher Jones | Feb 3, 2021 | 2 min read
The newly discovered microbe seems to be responsible for a mysterious neurological disease that has killed dozens of critically endangered Western chimpanzees.
Are Phages Overlooked Mediators of Health and Disease?
Catherine Offord | Feb 1, 2021 | 10+ min read
Bacteria-infecting viruses affect the composition and behavior of microbes in the mammalian gut—and perhaps influence human biology.
Infographic: Trans-kingdom Interactions in the Gut
Catherine Offord | Feb 1, 2021 | 1 min read
Phages interact with bacteria and eukaryotic cells in ways that researchers suspect influence mammalian health.
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021 | 3 min read
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Max Kozlov | Jan 21, 2021 | 5 min read
Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.
COVID-19, SARS-CoV-2, coronavirus, pandemic, variant, L452R, B.1.1.7, virus,
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021 | 2 min read
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021 | 5 min read
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
US Confirms World’s First SARS-CoV-2 Cases in Gorillas
Max Kozlov | Jan 12, 2021 | 2 min read
Zoo officials say the captive primates are recovering, but scientists worry the virus could spread quickly through dwindling wild populations.
Pregnant COVID-19 Patients
The Scientist | Jan 11, 2021 | 1 min read
See a news report on a study of expectant mothers with SARS-CoV-2 infections.
Human Fetuses Can Contract SARS-CoV-2, but It’s Rare
Ashley Yeager | Jan 1, 2021 | 10+ min read
Compared with Zika and cytomegalovirus, the virus that causes COVID-19 appears to have a harder time penetrating the placenta and moving to a woman’s unborn baby.
An End in Sight
Bob Grant | Jan 1, 2021 | 2 min read
Last year humanity confronted our biggest challenge in a century. Science helped us see the light at the end of the tunnel. But we need to keep moving forward to emerge.
Infographic: How SARS-CoV-2 Might Travel from Mom to Fetus
Ashley Yeager | Jan 1, 2021 | 1 min read
The virus rarely spreads from mother to child before birth, but it can—and researchers are starting to investigate the path it takes.
ADVERTISEMENT